Biomyf S 360mg Tablet

About

Biomyf S 360mg Tablet contains Mycophenolate Sodium, an enteric-coated immunosuppressant medication crucial for preventing organ rejection in patients who have undergone kidney, heart, or liver transplantation. It works by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), an enzyme essential for the de novo synthesis of guanosine nucleotides, which are vital for the proliferation of lymphocytes. By targeting this pathway, mycophenolate sodium effectively suppresses the activity of B and T lymphocytes, key components of the immune system responsible for recognizing and attacking transplanted organs. This selective action helps to reduce the body's immune response against the new organ, thereby ensuring graft survival and improving long-term outcomes for transplant recipients, while minimizing certain gastrointestinal side effects compared to other formulations.

Uses

• Prevention of kidney transplant rejection
• Prevention of heart transplant rejection
• Prevention of liver transplant rejection
• Management of certain autoimmune diseases

Directions For Use

Take this tablet on an empty stomach, at least one hour before or two hours after food, as directed by your transplant specialist. Do not crush or chew.

Benefits

• Effectively prevents organ transplant rejection
• Reduces immune system activity
• Improves graft survival rates
• Allows successful transplantation
• Manages specific autoimmune conditions
• May reduce steroid dependence

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Thrombocytopenia (low platelet count)
• Increased risk of infections
• Hypertension
• Headache
• Tremor
• Insomnia

Safety Measures

• Alcohol - Avoid alcohol due to increased risk of gastrointestinal side effects and potential liver toxicity.
• Pregnancy - Contraindicated due to a high risk of birth defects and miscarriage. Effective contraception is essential.
• Breastfeeding - Contraindicated due to potential for serious adverse effects in the infant.
• Liver - Use with caution in severe liver impairment; dose adjustment may be needed. Monitor liver function closely.
• Kidney - Dose adjustment may be required in severe renal impairment; monitor kidney function closely.
• Lung - Increased risk of opportunistic lung infections and interstitial lung disease; monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.